Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANTHEON-IO: Calcium Pantothenate with Immunotherapy in Melanoma
NCT06377111Phase 1Active, not recruiting
- Sponsor
- University Health Network
- Start
- Jun 2024
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of calcium pantothenate in melanoma, sponsored by University Health Network. Primary endpoint: Plasmatic concentration of pantothenic acid at 9 weeks. Started Jun 2024; status: active, not recruiting.
02
Drugs
calcium pantothenate
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT06377111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06377111.